Superior Planning, LLC’s Definium Therapeutics DFTX Stock Holding History

Superior Planning, LLC’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$28.8K	Buy	+756	New	+$31.9K	0.01%	556

Other funds holding DFTX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Superior Planning, LLC's DFTX Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Definium Therapeutics (DFTX) in Q3 2026: 756 shares worth $28.8K. The stake represents 0.01% of the portfolio and ranks #556 among its holdings.

197 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

Superior Planning, LLC held 756 shares of Definium Therapeutics worth $28.8K as of Q3 2026.
Definium Therapeutics was a new Superior Planning, LLC position in Q3 2026.
Definium Therapeutics made up 0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #556 holding.
197 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.